AVITA Medical (RCEL) Revenue (2018 - 2025)

AVITA Medical has reported Revenue for 8 years, with the latest figure at $92.0 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue rose 409.75% year-over-year to $92.0 million; the trailing twelve-month figure through Dec 2025 stood at $146.0 million (up 129.04% YoY), and the FY2025 full-year result was $70.9 million, up 10.93% from the prior year.
• Revenue for Q4 2025 stood at $92.0 million, up from $17.1 million in the prior quarter.
• The five-year high for Revenue was $92.0 million in Q4 2025, with the low at $7.0 million in Q3 2021.
• Historically, Revenue has averaged $17.3 million across 5 years, with a median of $12.7 million in 2023.
• Annual changes were most pronounced in 2022 — Revenue declined 13.99% — and 2025, when it jumped 409.75%.
• AVITA Medical's Revenue stood at $7.0 million in 2021, then surged by 34.69% to $9.5 million in 2022, then surged by 50.13% to $14.2 million in 2023, then grew by 27.14% to $18.0 million in 2024, then jumped by 409.75% to $92.0 million in 2025.
• The last three Revenue figures came in at $92.0 million (Q4 2025), $17.1 million (Q3 2025), and $18.4 million (Q2 2025), per Business Quant data.